Global trials fail when supply cannot adapt. See how IRT signals, dynamic forecasting, and risk triggers keep inventory aligned, prevent stockouts, and protect timelines.
- Why Good Data Still Fails: Inconsistency, Visibility, And Decision Risk
- Designing CNS Trial Supply Chains: A Technical Framework
- Primary Healthcare Disruption And Clinical Trial Supply Risk
- Protecting Clinical Trials From Global Supply Disruptions
- From Passive To Predictive: The New Era Of Clinical Cold Chain Management
- When Shipments Stop: Understanding And Managing Customs Delays In Clinical Supply Chains
- U.S. Pharma Tariffs And MFN Become Law After April 2 Update
- 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C
This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.
-
Streamlining Clinical Supply With Advanced Automation
Clinical trials are the backbone of pharmaceutical advancements, but they come with their own set of challenges, particularly in data management and supply chain logistics.
-
Critical Requirements In Sourcing Comparator Drugs
Sourcing comparator drugs has become complex in the clinical supply chain. As a result, clinical trial sponsors and pharma companies are eager to identify opportunities to overcome these challenges.
-
From Frustration To Organization: An SSO Platform For Trial Sites
To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
-
Rare Diseases And The Integrated CDMO Support System
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
RTSM Manages Clinical IP Dispensation In Schizophrenia Study
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
3 Study Areas Where Your IRT Vendor Should Do More
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Enhancing Clinical IP Efficiency & Compliance
A U.S.-based clinical research sponsor optimized their supply chain visibility, reduced costs and risks, and improved efficiency by replacing their manual inventory management system.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.